Literature DB >> 9916064

Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.

D P O'Brien1, D E Briles, A J Szalai, A H Tu, I Sanz, M H Nahm.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is important in resistance to various microorganisms and provides signals to the target cells through two different receptors, TNF-alpha receptor I (TNFRI) (p55 receptor) and TNFRII (p75 receptor). To delineate the significance of the two different signaling pathways in resisting infections with extracellular bacteria, we examined the resistance of mice to Streptococcus pneumoniae (serotype 6B). TNF-alpha needs to be present early in infections, since one injection of wild-type mice with anti-TNF-alpha leads to an increased susceptibility of these mice to S. pneumoniae. TNF-alpha signaling through the p55 receptor (but not the p75 receptor) is crucial in resisting S. pneumoniae infections, because intraperitoneal injection of 100 CFU/mouse killed p55-deficient mice by day 2 of infection, whereas 1,000,000 CFU/mouse was needed to kill half of the control mice. p55-deficient mice do not show evidence of a deficient acute-phase response. All three types of mice (p55 deficient, p75 deficient, and normal) showed comparable rises in the levels of two acute-phase proteins (serum amyloid P and C3) at 24, 48, and 72 h after the experimental infections, and all of the mice showed comparable influxes of neutrophils to the site of infection. Finally, it was demonstrated that p55-deficient mice can be protected from the lethal effects of S. pneumoniae infection by injection of antibodies specific for S. pneumoniae polysaccharide capsule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916064      PMCID: PMC96360     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

3.  Evidence that tumor necrosis factor has an important role in antibacterial resistance.

Authors:  E A Havell
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

4.  Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans.

Authors:  H L Collins; G J Bancroft
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

5.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

6.  Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice.

Authors:  S Steinshamn; A Waage
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes.

Authors:  B K Erikstein; E B Smeland; H K Blomhoff; S Funderud; K Prydz; W Lesslauer; T Espevik
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

8.  Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival.

Authors:  A K Franks; K I Kujawa; L J Yaffe
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins.

Authors:  R F Mortensen; J Shapiro; B F Lin; S Douches; R Neta
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

10.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

View more
  28 in total

Review 1.  Immunomodulation by thalidomide and thalidomide analogues.

Authors:  L G Corral; G Kaplan
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Pneumococci: immunology of the innate host response.

Authors:  Gavin K Paterson; Carlos J Orihuela
Journal:  Respirology       Date:  2010-07-20       Impact factor: 6.424

3.  Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

Authors:  Y i Hwang; M H Nahm; D E Briles; D Thomas; J M Purkerson
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Impaired pneumovax-23-induced monocyte-derived cytokine production in patients with common variable immunodeficiency.

Authors:  Raymond Hong; Sudhanshu Agrawal; Sastry Gollapudi; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

5.  The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.

Authors:  M Odeh; B Makhoul; E Sabo; I Srugo; A Oliven
Journal:  Lung       Date:  2005 Jan-Feb       Impact factor: 2.584

Review 6.  How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?

Authors:  Bärbel Schröfelbauer; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

7.  Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host.

Authors:  Y Mizrachi-Nebenzahl; S Lifshitz; R Teitelbaum; S Novick; A Levi; D Benharroch; E Ling; R Dagan
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

8.  Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.

Authors:  Tera L McCool; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 9.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Increased mortality and dysregulated cytokine production in tumor necrosis factor receptor 1-deficient mice following systemic Klebsiella pneumoniae infection.

Authors:  Thomas A Moore; Michelle L Perry; Andrew G Getsoian; Christine L Monteleon; Anna L Cogen; Theodore J Standiford
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.